Skip to main content

SNPS$430.89

Synopsys, Inc.

Last Updated
Jul 9, 20265 days ago
Moat & Trend
Management
Strong
Competitive Radar

Moat Score

76/100

Executive Summary

Synopsys has one of the strongest moats in enterprise software because its tools sit at the center of chip design, verification, and semiconductor IP reuse. The business benefits from very high switching costs, deep technical trust, and a concentrated industry structure dominated by a few vendors. Its brand and engineering reputation matter because a failed tool choice can delay or jeopardize a multi-billion-dollar tapeout. The moat is expanding beyond classic EDA through AI-driven design automation and the Ansys acquisition, which broadens Synopsys into a fuller chip-to-system workflow. Competitive pressure from Cadence and regulatory divestitures remain real, but they do not materially weaken the long-run structural advantage. Overall, Synopsys appears to have a wide, durable moat with improving strategic scope.

Sign in to see the full analysis

The Strategic Factor Breakdown, Management Quality Assessment, and AI Impact Assessment are available to registered users — it's free.

Last Updated
Jul 9, 20265 days ago
Target Price
Analyst Consensus
Buy24 analysts
FAIR VALUE
Financial Strength

Financial Score

64/100

Executive Summary

Synopsys’ most notable strength remains its high-quality software-style earnings engine, with revenue compounding from $4.2B to $7.1B in FY21–FY25 and TTM revenue of $8.7B pointing to renewed acceleration. Margins are still attractive in absolute terms, but operating margin has compressed meaningfully, and reported net income has been flattered by unusual other income and discontinued-items gains, tempering the income statement’s apparent strength. Cash generation remains solid, with positive free cash flow throughout, though working-capital volatility and aggressive buybacks add some noise. The main tension is the balance sheet: FY25’s acquisition-driven jump in goodwill, intangibles, and debt left tangible equity deeply negative and liquidity less robust. Efficiency and returns have also weakened sharply. Overall, Synopsys looks fundamentally resilient but more leveraged and less efficient than before, consistent with its mixed middle-of-the-road to above-average ratings profile.

Sign in to see the full analysis

The Income Statement, Balance Sheet, Cash Flow, Key Ratios, Forecast, and Fair Value analysis are available to registered users — it's free.

Last Updated
Jul 9, 2026
Short Term
Bearish1–4 weeks
Medium Term
Bearish1–6 months
Long Term
Bearish6m+
Price Outlook
$434.50Price at Analysis

The path of least resistance remains lower unless SNPS can reclaim the $436.38–$437.63 area, which would ease immediate downside pressure. The most probable next move is a continued test of support around $432.28 and $428.18, with $421.54 and the monthly $421.06 area the key downside risk if selling resumes.

Technical Overview

SNPS is technically damaged across the board, with the sharp daily decline reinforcing a bearish near-term tone. Short-term momentum is weak: price is below the 20-day average, RSI is still subdued, MACD remains negative, and volume is contracting, so there is little evidence of an immediate momentum turn. The medium-term picture is only marginally better, as the recent Golden Cross offers a constructive backdrop, but price remains below the 50-day and 200-day averages and the broader trend is still downward. Long term, the stock remains in the lower third of its 52-week range, leaving the chart vulnerable until it can rebuild above the high-$430s. Key levels to watch are $432.28 and $428.18 on the downside, with $437.63 and then $456.33 as the first meaningful resistance zones.

Sign in for the full breakdown

See the full short, medium & long-term indicator breakdowns and support/resistance levels — free for registered users.

Disclaimer: The analysis on this page is generated by AI and is provided for informational purposes only. It does not constitute financial advice, investment recommendations, or an offer to buy or sell any security. Always conduct your own due diligence and consult a qualified financial adviser before making any investment decisions.